Valuation: ORIENT BIO Inc.

Market Cap 110B 147,707B 97.45B 90.95B 82.9B 156B 10,543B 158B 1,101B 427B 5,390B 412B 403B 17,298B P/E 2020
-5.36x
P/E 2021 -11.4x
Enterprise Value 106B 142,813B 94.22B 87.94B 80.15B 151B 10,194B 153B 1,064B 412B 5,211B 398B 389B 16,725B EV / Sales 2020
1.66x
EV / Sales 2021 3.53x
Free-Float
59.8%
Yield 2020 *
-
Yield 2021 -
07-08 Orient Precision Industries Inc announced that it has received KRW 2.8975 billion in funding from ORIENT BIO Inc. CI
06-23 Orient Precision Industries Inc announced that it expects to receive KRW 2.8975 billion in funding from ORIENT BIO Inc. CI
02-23 Orient Precision Industries Inc announced that it has received KRW 3.138 billion in funding from ORIENT BIO Inc. CI
02-10 Orient Precision Industries Inc announced that it expects to receive KRW 3.138 billion in funding from ORIENT BIO Inc. CI
12-02 Orient Bio to sell 9.4 billion won of own shares RE
11/08/25 Alerts on CEO and chairman appointment wrongly tagged to Orient Bio withdrawn RE
16/12/22 Pregen Inc. announced that it has received KRW 1.7 billion in funding from Orient Co.,Ltd, ORIENT BIO Inc., ORIENT WATCH CO.,LTD. CI
01/12/22 Pregen Inc. announced that it expects to receive KRW 1.7 billion in funding from Orient Co.,Ltd, ORIENT BIO Inc., ORIENT WATCH CO.,LTD. and other investors CI
10/08/22 Orient Electronics Co.,Ltd. announced that it has received KRW 3.049998525 billion in funding from Orient Precision Industries Inc, ORIENT BIO Inc. CI
20/07/22 Orient Electronics Co.,Ltd. announced that it expects to receive KRW 3.049998525 billion in funding from Orient Precision Industries Inc, ORIENT BIO Inc. CI
14/02/22 ORIENT BIO Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
27/01/22 Inotiv, Inc. acquired Orient BioResource Center, Inc. from ORIENT BIO Inc. for $51.3 million. CI
15/11/21 ORIENT BIO Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
1 day+0.74%
1 week-10.33%
Current month-0.12%
1 month-10.19%
3 months-6.29%
6 months-28.07%
Current year-31.78%
1 week 1,611
Extreme 1611
1,824
1 month 1,611
Extreme 1611
1,936
Current year 1,490
Extreme 1490
3,264
1 year 1,490
Extreme 1490
3,264
3 years 1,490
Extreme 1490
10,240
5 years 1,490
Extreme 1490
10,240
10 years 1,490
Extreme 1490
21,598.54
Manager TitleAgeSince
Chief Executive Officer 65 05/10/2010
Corporate Officer/Principal 36 28/06/2024
Corporate Officer/Principal 49 -
Director TitleAgeSince
Chairman 65 05/10/2010
Director/Board Member 62 01/07/2003
Director/Board Member 68 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%-10.33%-29.07%-38.71% 36.1M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+21.92%+74.60% 57.39B
+0.89%-0.63%+4.28%+34.51% 47.64B
+0.36%+0.81%+352.17%+689.61% 44.29B
-0.96%-4.50%+26.36%+33.18% 42.5B
-0.20%-0.77%+3.74%+100.60% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.63%+19.50% 28.53B
+0.05%-1.64%-7.28%-14.06% 24.34B
Average -0.13%-1.38%+46.04%+104.38% 39.06B
Weighted average by Cap. +0.12%-0.84%+58.76%+129.89%

Financials

2020 2021
Net sales 37.7B 50,772B 33.5B 31.26B 28.5B 53.74B 3,624B 54.24B 378B 147B 1,853B 142B 138B 5,946B 52.02B 70,059B 46.22B 43.14B 39.32B 74.16B 5,001B 74.85B 522B 202B 2,557B 195B 191B 8,205B
Net income -10.88B -14,654B -9.67B -9.02B -8.22B -15.51B -1,046B -15.66B -109B -42.31B -535B -40.85B -39.97B -1,716B -15.63B -21,055B -13.89B -12.96B -11.82B -22.29B -1,503B -22.49B -157B -60.8B -768B -58.7B -57.42B -2,466B
Net Debt 4.07B 5,477B 3.61B 3.37B 3.07B 5.8B 391B 5.85B 40.81B 15.81B 200B 15.27B 14.94B 641B -3.63B -4,893B -3.23B -3.01B -2.75B -5.18B -349B -5.23B -36.46B -14.13B -179B -13.64B -13.35B -573B
Logo ORIENT BIO Inc.
Orient Bio Inc is a Korea-based company engaged in the biotechnology area. The Company produces and supplies laboratory animals, including mice, rats, guinea pigs, hamsters, specific pathogen free (SPF) rabbits, beagles and others. It also provides contract research organization (CRO) services, including CRO safety assessment and CRO new drug development services; medical and library equipment, such as barrier systems, and support services such as rodent surgery services, laboratory diagnostics services, transgenic services, genetic testing services and other services. In addition, along with its subsidiaries, the Company provides feeds, reagents, disinfectants, automobile components, power supply equipment, and other machines.
Employees
125
Date Price Change Volume
02/10/26 ₩1,640.00 +0.74% 27,445
01/10/26 ₩1,628.00 -0.85% 50,565
30/09/26 ₩1,642.00 -3.47% 113,919
29/09/26 ₩1,701.00 -5.13% 78,882
28/09/26 ₩1,793.00 -1.97% 61,302
  1. Stock Market
  2. Stocks
  3. A002630 Stock